2 citations
,
December 2018 in “International journal of current microbiology and applied sciences”
In this case study, a 7-year-old Labrador with hypothyroidism and alopecia showed dramatic improvement and complete hairregrowth after two months of Levothyroxine and Ketoconazole treatment.
6 citations
,
January 2015 in “Indian Dermatology Online Journal”
This study observed that an overdose of levothyroxine in a hypothyroid infant led to rapid hair loss, which improved after reducing the medication dose.
In this study, researchers observed that fasting-induced molting in laying hens led to increased thyroid hormones, which may regulate feather molting by affecting hair follicle growth through specific signaling pathways, highlighting molecular changes during induced molting.
80 citations
,
September 1984 in “Journal of The American Academy of Dermatology”
In this study, 5% topical minoxidil was observed to promote hairregrowth in some patients with androgenic alopecia, while no regrowth was noted in patients with alopecia areata.
5 citations
,
April 2019 in “Plastic and reconstructive surgery. Global open”
This literature review suggests that fractional laser therapies may positively impact hairregrowth in androgenic alopecia, though current evidence is mostly limited to small studies and case reports, highlighting a need for more comprehensive randomized controlled trials to confirm their efficacy and safety.
A 25-year-old male with 10 years of hair loss is using minoxidil and considering adding finasteride or dutasteride, possibly with microneedling, to improve hairregrowth before a hair transplant. Community members suggest starting a DHT blocker immediately, considering oral minoxidil, and addressing low vitamin D and HDL levels.
A 23-year-old man with hair loss, despite using dutasteride, oral minoxidil, and RU58841, is considering bicalutamide for regrowth but is concerned about feminization. Alternatives like topical estrogen, JXL069, and spironolactone are discussed, with suggestions to explore thyroid levels and other potential underlying conditions.
The user experienced significant hairregrowth in three months using a capsule containing minoxidil and finasteride. They reported no major side effects and plan to continue the treatment until their late 20s.
A user shared their hairregrowth progress using Dutasteride, topical Minoxidil, Spironolactone, and Estradiol Valerate injections as part of hormone replacement therapy for transitioning. They experienced significant hair improvement and personal satisfaction but caution against this approach for non-transitioning individuals due to irreversible changes.
The user has been using finasteride for six years and minoxidil for three years with no noticeable hairregrowth. Suggestions include switching to dutasteride, considering a hair transplant, and trying microneedling.